ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07885
0,00%
Bitcoin
60.775,02
-0,03%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AYTU BioPharma Inc (AYTU)

  7. AYTU BioPharma Inc (AYTU) News

AYTU

AYTU BioPharma (AYTU)

AYTU BioPharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AYTU
DatumZeitQuelleÜberschriftSymbolFirma
10/05/202422h07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AYTUAYTU BioPharma Inc
10/05/202422h07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AYTUAYTU BioPharma Inc
10/05/202422h06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AYTUAYTU BioPharma Inc
14/02/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
13/02/202422h25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AYTUAYTU BioPharma Inc
02/01/202422h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
17/11/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
14/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AYTUAYTU BioPharma Inc
26/10/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
12/10/202320h50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AYTUAYTU BioPharma Inc
06/10/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
03/10/202322h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
29/09/202322h15Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:AYTUAYTU BioPharma Inc
27/09/202322h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
27/09/202313h28IH Market NewsWednesday’s Wall Street Highlights: Amazon, Costco, Sirius XM, Electronic Arts, Peloton, and moreNASDAQ:AYTUAYTU BioPharma Inc
19/08/202300h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
16/08/202302h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
16/08/202301h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
16/08/202301h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
16/08/202301h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
16/08/202301h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
16/08/202301h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
16/08/202301h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
16/08/202301h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
15/08/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
31/07/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
10/07/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
10/07/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
06/07/202321h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
23/06/202322h55Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AYTUAYTU BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:AYTU

Kürzlich von Ihnen besucht

NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
SOLUSD
Solana
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
XOM
Exxon Mobil
TG
BAS
BASF
TG
CBK
Commerzbank
TG
BAYN
Bayer
NYSE
KO
Coca Cola
TG
TUI1
Tui
PM
XAUUSD
Gold vs US Dollar
TG
ALV
Allianz
USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
DBI
TDXP
Tec DAX
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten